Phase II Study of Antineoplastons A10 and AS2-1 in Children With High Grade Glioma.
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2017
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 01 Aug 2017 Status changed from active, no longer recruiting to discontinued.
- 21 Jul 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Aug 2005 New trial record.